Login / Signup

Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison.

Audrey ValdesLoic EpelboinEmilie MosnierGaelle WalterGuillaume VesinPhilippe AbboudAlessia MelzaniDenis BlanchetNicaise BlaiseMathieu NacherMagalie DemarFelix Djossou
Published in: Malaria journal (2018)
There were no significant differences between primaquine at 15 or 30 mg/day for 14 days in the prevention of P. vivax relapses at 2, 3 and 6 months after primaquine treatment in French Guiana.
Keyphrases